Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)

NACompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

February 18, 2023

Study Completion Date

November 17, 2023

Conditions
Drug-Coated BalloonDe Novo StenosisAcute Coronary SyndromesACSDCBClinical TrialCoronary Artery Disease
Interventions
DEVICE

Drug-coated balloon

Drug-coated balloon is a fast-exchange balloon dilatation catheter, used to treat coronary artery stenosis lesions and improve myocardial blood flow.

DEVICE

Zotarolimus-Eluting Coronary Stent

Zotarolimus-Eluting Coronary Stent is treated for coronary artery stenosis lesions .

Trial Locations (1)

150081

The Second Affiliated Hospital of Harbin Medical University, Harbin

All Listed Sponsors
collaborator

Daqing Oil Field Hospital

OTHER

collaborator

Sichuan Provincial People's Hospital

OTHER

collaborator

Tianjin People's Hospital

OTHER

collaborator

Peking University First Hospital

OTHER

collaborator

Beijing Friendship Hospital

OTHER

collaborator

The Third Medical Center, Chinese PLA General Hospital

UNKNOWN

collaborator

Jining Medical University

OTHER

collaborator

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

collaborator

The First Hospital of Jilin University

OTHER

collaborator

General Hospital of Taiyuan Iron & Steel Company

UNKNOWN

collaborator

Tongji Hospital

OTHER

collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

Second Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Sir Run Run Shaw Hospital

OTHER

collaborator

Inner Mongolia People's Hospital

OTHER

lead

Harbin Medical University

OTHER